Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Convertible Debt (2023 - 2024)

Bioharvest Sciences has reported Convertible Debt over the past 2 years, most recently at $1.2 million for Q3 2024.

  • For Q3 2024, Convertible Debt changed N/A year-over-year to $1.2 million; the TTM value through Sep 2024 reached $1.2 million, changed N/A, while the annual FY2023 figure was $20.5 million, N/A changed from the prior year.
  • Convertible Debt was $1.2 million for Q3 2024 at Bioharvest Sciences, up from $1.2 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $20.5 million in Q4 2023 and bottomed at $1.2 million in Q2 2024.